GlassScriptPhysician profile
Craig A Cherrin
NPI 1194267625
$2,616.59
in general payments reported to CMS, 2019-2025
18 companies · $1,005 in 2025
The $1,005 reported for 2025 was more than what 85% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $146 · 2022: $586 · 2023: $583 · 2024: $297 · 2025: $1,005.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,885.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,884.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $662.54 | 2022-2025 | Wegovy, Ozempic |
| Astrazeneca Pharmaceuticals LP | $310.75 | 2024-2025 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $236.14 | 2022-2023 | |
| Amgen INC. | $194.72 | 2022-2025 | |
| Abbott Laboratories | $170.12 | 2022-2025 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $125.97 | 2022-2023 | |
| Collegium Pharmaceutical, INC. | $125.00 | 2025 | Jornay Pm |
| Verrica Pharmaceuticals INC. | $125.00 | 2023 | Ycanth |
| Ars Pharmaceuticals Operations, INC. | $124.99 | 2025 | Neffy |
| Biohaven Pharmaceuticals, INC. | $113.70 | 2021 | |
| Novartis Pharmaceuticals Corporation | $98.48 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $91.63 | 2022-2023 | Jardiance |
| Dexcom, INC. | $77.65 | 2022-2023 | Dexcom G6 Transmitter |
| Orthofix Medical, INC. | $55.73 | 2021-2022 | |
| Medtronic, INC. | $35.82 | 2022-2023 | Intellis Adaptivestim |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $28.97 | 2022-2023 | Quviviq |
| Sanofi-Aventis U.S. LLC | $21.95 | 2022 | |
| Pfizer INC. | $17.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Cherrin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.